WO2019059722A3 - 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들 - Google Patents

부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들 Download PDF

Info

Publication number
WO2019059722A3
WO2019059722A3 PCT/KR2018/011267 KR2018011267W WO2019059722A3 WO 2019059722 A3 WO2019059722 A3 WO 2019059722A3 KR 2018011267 W KR2018011267 W KR 2018011267W WO 2019059722 A3 WO2019059722 A3 WO 2019059722A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
needle
micro
same
treating
Prior art date
Application number
PCT/KR2018/011267
Other languages
English (en)
French (fr)
Other versions
WO2019059722A9 (ko
WO2019059722A2 (ko
Inventor
양승윤
안범수
성금용
안성민
Original Assignee
부산대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 부산대학교 산학협력단 filed Critical 부산대학교 산학협력단
Publication of WO2019059722A2 publication Critical patent/WO2019059722A2/ko
Publication of WO2019059722A3 publication Critical patent/WO2019059722A3/ko
Publication of WO2019059722A9 publication Critical patent/WO2019059722A9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명의 조성물 및 이를 포함하는 부분 비만 치료용 마이크로니들에서, 본 발명의 조성물은 젤라틴을 포함하고, 체내 지방을 분해하고 체내 지방 생성 및 축적을 억제한다.
PCT/KR2018/011267 2017-09-22 2018-09-21 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들 WO2019059722A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170122902 2017-09-22
KR10-2017-0122902 2017-09-22

Publications (3)

Publication Number Publication Date
WO2019059722A2 WO2019059722A2 (ko) 2019-03-28
WO2019059722A3 true WO2019059722A3 (ko) 2019-07-04
WO2019059722A9 WO2019059722A9 (ko) 2019-08-15

Family

ID=65810459

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/011267 WO2019059722A2 (ko) 2017-09-22 2018-09-21 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들

Country Status (2)

Country Link
KR (1) KR102136006B1 (ko)
WO (1) WO2019059722A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102173864B1 (ko) * 2019-12-20 2020-11-04 주식회사 에이엠메딕스 지방 분해 물질 및 이의 제조 방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254440A (ja) * 2006-03-27 2007-10-04 Ihara Suisan Kk 脂質代謝調節剤及び脂質代謝調節食品
KR20150138647A (ko) * 2014-06-02 2015-12-10 주식회사 아모그린텍 마이크로 니들 패치 및 그의 제조 방법
KR101688924B1 (ko) * 2012-06-21 2016-12-22 바이오스트림테크놀러지스(주) 히알루론산의 항비만 효과
KR101806074B1 (ko) * 2017-05-26 2017-12-07 유승민 지방분해용 조성물
KR20180025220A (ko) * 2016-08-31 2018-03-08 주식회사 에스엔비아 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010085047A (ko) * 2001-07-25 2001-09-07 장태순 고분자 수용성 키토산의 고지방 식이에 의한 체 지방 증가억제 효과
JP2006191830A (ja) * 2005-01-12 2006-07-27 Unitika Ltd 脂肪の蓄積を抑制する食品
KR101751953B1 (ko) * 2015-05-28 2017-07-03 주식회사 엘지생활건강 염화수화물 마이크로 니들 및 그 제작방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254440A (ja) * 2006-03-27 2007-10-04 Ihara Suisan Kk 脂質代謝調節剤及び脂質代謝調節食品
KR101688924B1 (ko) * 2012-06-21 2016-12-22 바이오스트림테크놀러지스(주) 히알루론산의 항비만 효과
KR20150138647A (ko) * 2014-06-02 2015-12-10 주식회사 아모그린텍 마이크로 니들 패치 및 그의 제조 방법
KR20180025220A (ko) * 2016-08-31 2018-03-08 주식회사 에스엔비아 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들
KR101806074B1 (ko) * 2017-05-26 2017-12-07 유승민 지방분해용 조성물

Also Published As

Publication number Publication date
KR102136006B1 (ko) 2020-07-20
KR20190034122A (ko) 2019-04-01
WO2019059722A9 (ko) 2019-08-15
WO2019059722A2 (ko) 2019-03-28

Similar Documents

Publication Publication Date Title
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
AU2018263868A1 (en) Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
PH12016500270A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases
EP3661993A4 (en) POLYETHER DERIVATIVES, THEIR USES AND THEIR MANUFACTURING PROCESSES
MX2016014408A (es) Emulsion de agua en aceite para el cuidado de la piel.
EP3680331A4 (en) MODIFIED CAS9 PROTEIN AND USING IT
MX2019002960A (es) Oligonucleótidos modificados y métodos de uso.
MX2021010886A (es) Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
IL271728A (en) Materials, uses and treatment methods
GB201815025D0 (en) Insect-pathogenic fungus, spores, composition and use of same
EP3702470A3 (en) Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
MX2022006154A (es) Combinaciones y sus usos.
PH12018550008A1 (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
EP3654979A4 (en) USING WX-UK1 AND ITS PRODRUG, WX-671, FOR TREATMENT OF NON CANCER DISEASES
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
WO2019059722A3 (ko) 부분 비만 치료용 조성물 및 이를 포함하는 마이크로니들
WO2016046759A3 (en) Compositions and methods for treating friedreich's ataxia
GB2579240B (en) New processes, compositions and medical uses
WO2018211323A8 (en) Heterocyclic compounds for the treatment of disease
EP3626224A4 (en) MULTI-AGENT TYPE HAIR TREATMENT AGENT
EP3501494A4 (en) ANTI-WRINKLE COSMETIC COMPOSITION, USE OF THIS COMPOSITION AND ANTI-WRINKLE TREATMENT METHOD
EP3501491A4 (en) ANTI-WRINKLE COSMETIC COMPOSITION, USE OF THIS COMPOSITION AND ANTI-WRINKLE TREATMENT METHOD
SI3353164T1 (sl) Bi-heteroaril substituiran 1,4-benzodiazepini in njihove uporabe za zdravljenje raka

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18857833

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18857833

Country of ref document: EP

Kind code of ref document: A2